U
BioTech Medics, Inc. BMCS
OTC PK
Recommendation
--
Prev Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

03/31/2012
Total Cash And Short-Term Investments 1.30K
Total Receivables --
Inventory 14.50K
Prepaid Expenses --
Finance Division Loans and Leases Current --
Total Finance Division Other Current Assets --
Other Current Assets --
Total Current Assets 15.80K

Total Current Assets 15.80K
Net Property, Plant & Equipment 5.06M
Long-term Investments --
Goodwill --
Total Other Intangibles 0.00
Finance Div Loans & Leases LT --
Total Finance Div Other LT Assets --
Total Other Assets --
Total Assets 5.07M

Total Accounts Payable 17.00K
Total Accrued Expenses --
Short-term Debt 28.90K
Current Portion of Long-Term Debt/Capital Leases --
Finance Division Debt Current --
Total Finance Division Other Current Liabilities 2.08M
Total Other Current Liabilities 2.08M
Total Current Liabilities 2.12M

Total Current Liabilities 2.12M
Long-Term Debt --
Short-term Debt 28.90K
Capital Leases --
Finance Division Debt Non Current --
Total Finance Division Other Non Current Liabilities --
Total Other Liabilities --
Total Liabilities 2.12M

Common Stock & APIC 2.07M
Retained Earnings -1.75M
Treasury Stock & Other 2.64M
Total Common Equity 2.95M

Preferred Stock Redeemable --
Preferred Stock Non Redeemable --
Preferred Stock Convertible --
Preferred Stock, Others --
Total Preferred Equity --

Total Common Equity 2.95M
Total Preferred Equity --
Total Minority Interest --
Total Equity 2.95M

Weiss Ratings